Constitutive deficiency in DNA mismatch repair

Clinical Genetics

Volumn 71, Issue 6, 2007, Pages 483-498

  Felton, K E A ^a   Gilchrist, D M ^a   Andrew, Susan E ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

DNA mismatch repair; Hereditary non polyposis colorectal cancer; Lynch syndrome; Microsatellite instability; Neurofibromatosis type 1

Indexed keywords

MISMATCH REPAIR PROTEIN PMS2; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH3; PROTEIN MSH6;

AMINO ACID DEFICIENCY; AMINO ACID SEQUENCE; BRAIN CANCER; COLORECTAL CANCER; FAMILIAL CANCER; FRAMESHIFT MUTATION; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOHISTOCHEMISTRY; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MISSENSE MUTATION; NEUROFIBROMATOSIS; NUCLEOTIDE SEQUENCE; NULL ALLELE; ONSET AGE; PATHOGENICITY; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; TURCOT SYNDROME;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOSINE TRIPHOSPHATASES; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MISMATCH REPAIR; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; HUMANS; MUTATION; MUTS HOMOLOG 2 PROTEIN; NUCLEAR PROTEINS;

EID: 34249723181     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2007.00803.x     Document Type: Review

References (86)

1. Iyer RR, Pluciennik A, Burdett V et al. DNA mismatch repair: Functions and mechanisms. Chem Rev 2006: 106: 302-323.
2. Chao EC, Lipkin SM. Molecular models for the tissue specificity of DNA mismatch repair-deficient carcinogenesis. Nucleic Acids Res 2006: 34 (3): 840-852.
3. Umar A, Risinger JI, Hawk ET et al. Testing guidelines for hereditary non-polyposis colorectal cancer. Nat Rev Cancer 2004: 4 (2): 153-158.
4. Baglioni S, Genuardi M. Simple and complex genetics of colorectal cancer susceptibility. Am J Med Genet C Semin Med Genet 2004: 129 (1): 35-43.
5. Lucci-Cordisco E, Zito I, Gensini F et al. Hereditary nonpolyposis colorectal cancer and related conditions. Am J Med Genet 2003: 122A (4): 325-334.
6. Hampel H, Peltomaki P. Hereditary colorectal cancer: Risk assessment and management. Clin Genet 2000: 58 (2): 89-97.
7. Paraf F, Jothy S, Van Meir EG. Brain tumor-polyposis syndrome: Two genetic diseases? J Clin Oncol 1997: 15 (7): 2744-2758.
8. De Rosa M, Fasano C, Panariello L et al. Evidence for a recessive inheritance of Turcot's syndrome caused by compound heterozygous mutations within the PMS2 gene. Oncogene 2000: 19 (13): 1719-1723.
9. Hamilton SR, Liu B, Parsons RE et al. The molecular basis of Turcot's syndrome. N Engl J Med 1995: 332 (13): 839-847.
10. de la Chapelle A. Genetic predisposition to colorectal cancer. Nat Rev Cancer 2004: 4 (10): 769-780.
11. Peltomaki P, Vasen H. Mutations associated with HNPCC predisposition -update of ICG-HNPCC/INSiGHT mutation database. Dis Markers 2004: 20 (4-5): 269-276.
12. Truninger K, Menigatti M, Luz J et al. Immunohistochemical analysis reveals high frequency of PMS2 defects in colorectal cancer. Gastroenterology 2005: 128 (5): 1160-1171.
13. Ricciardone MD, Ozcelik T, Cevher B et al. Human MLH1 deficiency predisposes to hematological malignancy and neurofibromatosis type 1. Cancer Res 1999: 59 (2): 290-293.
14. Vilkki S, Tsao JL, Loukola A et al. Extensive somatic microsatellite mutations in normal human tissue. Cancer Res 2001: 61 (11): 4541-4544.
15. Wang Q, Lasset C, Desseigne F et al. Neurofibromatosis and early onset of cancers in hMLH1-deficient children. Cancer Res 1999: 59 (2): 294-297.
16. Bertholon J, Wang Q, Galmarini CM et al. Mutational targets in colorectal cancer cells with microsatellite instability. Fam Cancer 2006: 5 (1): 29-34.
17. Moslein G, Tester DJ, Lindor NM et al. Microsatellite instability and mutation analysis of hMSH2 and hMLH1 in patients with sporadic, familial and hereditary colorectal cancer. Hum Mol Genet 1996: 5 (9): 1245-1252.
18. Wehner M, Buschhausen L, Lamberti C et al. Hereditary nonpolyposis colorectal cancer (HNPCC): Eight novel germline mutations in hMSH2 or hMLH1 genes. Hum Mutat 1997: 10 (3): 241-244.
19. Wagner A, Reddinguis R, Kros J et al. Wilms tumor and glioblastoma in a child with a double MLH1 germline mutation. Fam Cancer 2003: 2 (Suppl. 1): 57.
20. Gallinger S, Aronson M, Shayan K et al. Gastrointestinal cancers and neurofibromatosis type 1 features in children with a germline homozygous MLH1 mutation. Gastroenterology 2004: 126 (2): 576-585.
21. Raevaara TE, Gerdes AM, Lonnqvist KE et al. HNPCC mutation MLH1 P648S makes the functional protein unstable, and homozygosity predisposes to mild neurofibromatosis type 1. Genes Chromosomes Cancer 2004: 40 (3): 261-265.
22. Durno C, Aronson M, Bapat B et al. Family history and molecular features of children, adolescents, and young adults with colorectal carcinoma. Gut 2005: 54 (8): 1146-1150.
23. Marcos I, Borrego S, Urioste M et al. Mutations in the DNA mismatch repair gene MLH1 associated with early-onset colon cancer. J Pediatr 2006: 148 (6): 837-839.
24. Huang SC, Lavine JE, Boland PS et al. Germline characterization of early-aged onset of hereditary non-polyposis colorectal cancer. J Pediatr 2001: 138 (5): 629-635.
25. Quaresima B, Alifano P, Tassone P et al. Human mismatch-repair protein MutL homologue 1 (MLH1) interacts with Escherichia coli MutL and MutS in vivo and in vitro: A simple genetic system to assay MLH1 function. Biochem J 2003: 371 (Pt 1): 183-189.
26. Shimodaira H, Filosi N, Shibata H et al. Functional analysis of human MLH1 mutations in Saccharomyces cerevisiae. Nat Genet 1998: 19 (4): 384-389.
27. Rey JM, Noruzinia M, Brouillet JP et al. Six novel heterozygous MLH1, MSH2, and MSH6 and one homozygous MLH1 germline mutations in hereditary nonpolyposis colorectal cancer. Cancer Genet Cytogenet 2004: 155 (2): 149-151.
28. Liu T, Tannergard P, Hackman P et al. Missense mutations in hMLH1 associated with colorectal cancer. Hum Genet 1999: 105 (5): 437-441.
29. Hackman P, Tannergard P, Osei-Mensa S et al. A human compound heterozygote for two MLH1 missense mutations. Nat Genet 1997: 17 (2): 135-136.
30. Bougeard G, Charbonnier F, Moerman A et al. Early onset brain tumor and lymphoma in MSH2-deficient children. Am J Hum Genet 2003: 72 (1): 213-216.
31. Whiteside D, McLeod R, Graham G et al. A homozygous germ-line mutation in the human MSH2 gene predisposes to hematological malignancy and multiple cafe-au-lait spots. Cancer Res 2002: 62 (2): 359-362.
32. Kolodner RD, Hall NR, Lipford J et al. Structure of the human MSH2 locus and analysis of two Muir-Torre kindreds for msh2 mutations. Genomics 1994: 24 (3): 516-526.
33. Muller A, Schackert HK, Lange B et al. A novel MSH2 germline mutation in homozygous state in two brothers with colorectal cancers diagnosed at the age of 11 and 12 years. Am J Med Genet A 2006: 140 (3): 195-199.
34. Wijnen J, de Leeuw W, Vasen H et al. Familial endometrial cancer in female carriers of MSH6 germline mutations. Nat Genet 1999: 23 (2): 142-144.
35. Hendriks YM, Wagner A, Morreau H et al. Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: Impact on counseling and surveillance. Gastroenterology 2004: 127 (1): 17-25.
36. Hegde MR, Chong B, Blazo ME et al. A homozygous mutation in MSH6 causes Turcot syndrome. Clin Cancer Res 2005: 11 (13): 4689-4693.
37. Menko FH, Kaspers GL, Meijer GA et al. A homozygous MSH6 mutation in a child with cafe-au-lait spots, oligodendroglioma and rectal cancer. Fam Cancer 2004: 3 (2): 123-127.
38. Ostergaard JR, Sunde L, Okkels H. Neurofibromatosis von Recklinghausen type I phenotype and early onset of cancers in siblings compound heterozygous for mutations in MSH6. Am J Med Genet A 2005: 139 (2): 96-105; discussion 196.
39. Scott RH, Mansour S, Pritchard-Jones K et al. Medulloblastoma, acute myelocytic leukemia and colonic carcinomas in a child with biallelic MSH6 mutations. Nat Clin Pract Oncol 2007: 4 (2): 130-134.
40. Abdel-Rahman WM, Ollikainen M, Kariola R et al. Comprehensive characterization of HNPCC-related colorectal cancers reveals striking molecular features in families with no germline mismatch repair gene mutations. Oncogene 2005: 24 (9): 1542-1551.
41. Plaschke J, Linnebacher M, Kloor M et al. Compound heterozygosity for two MSH6 mutations in a patient with early onset of HNPCC-associated cancers, but without hematological malignancy and brain tumor. Eur J Hum Genet 2006: 14 (5): 561-566.
42. Worthley DL, Walsh MD, Barker M et al. Familial mutations in PMS2 can cause autosomal dominant hereditary nonpolyposis colorectal cancer. Gastroenterology 2005: 128 (5): 1431-1436.
43. Chadwick RB, Meek JE, Prior TW et al. Polymorphisms in a pseudogene highly homologous to PMS2. Hum Mutat 2000: 16 (6): 530.
44. De Vos M, Hayward BE, Picton S et al. Novel PMS2 pseudogenes can conceal recessive mutations causing a distinctive childhood cancer syndrome. Am J Hum Genet 2004: 74 (5): 954-964.
45. Horii A, Han HJ, Sasaki S et al. Cloning, characterization and chromosomal assignment of the human genes homologous to yeast PMS1, a member of mismatch repair genes. Biochem Biophys Res Commun 1994: 204 (3): 1257-1264.
46. Nicolaides NC, Papadopoulos N, Liu B et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994: 371 (6492): 75-80.
47. Osborne LR, Herbrick JA, Greavette T et al. PMS2-related genes flank the rearrangement breakpoints associated with Williams syndrome and other diseases on human chromosome 7. Genomics 1997: 45 (2): 402-406.
48. Valero MC, de Luis O, Cruces J et al. Fine-scale comparative mapping of the human 7q11.23 region and the orthologous region on mouse chromosome 5G: The low-copy repeats that flank the Williams-Beuren syndrome deletion arose at breakpoint sites of an evolutionary inversion(s). Genomics 2000: 69 (1): 1-13.
49. Clendenning M, Hampel H, Lajeunesse J et al. Long-range PCR facilitates the identification of PMS2-specific mutations. Hum Mutat 2006: 27 (5): 490-495.
50. Hendriks YM, Jagmohan-Changur S, van der Klift HM et al. Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome). Gastroenterology 2006: 130 (2): 312-322.
51. Nakagawa H, Lockman JC, Frankel WL et al. Mismatch repair gene PMS2: disease-causing germline mutations are frequent in patients whose tumors stain negative for PMS2 protein, but paralogous genes obscure mutation detection and interpretation. Cancer Res 2004: 64 (14): 4721-4727.
52. Taylor MD, Perry J, Zlatescu MC et al. The hPMS2 exon 5 mutation and malignant glioma. Case report. J Neurosurg 1999: 90 (5): 946-950.
53. Thompson E, Meldrum CJ, Crooks R et al. Hereditary non-polyposis colorectal cancer and the role of hPMS2 and hEXO1 mutations. Clin Genet 2004: 65 (3): 215-225.
54. de Vos M, Hayward B, Bonthron DT et al. Phenotype associated with recessively inherited mutations in DNA mismatch repair (MMR) genes. Biochem Soc Trans 2005: 33 (Pt 4): 718-720.
55. Trimbath JD, Petersen GM, Erdman SH et al. Cafe-au-lait spots and early onset colorectal neoplasia: A variant of HNPCC? Fam Cancer 2001: 1 (2): 101-105.
56. Agostini M, Tibiletti MG, Lucci-Cordisco E et al. Two PMS2 mutations in a Turcot syndrome family with small bowel cancers. Am J Gastroenterol 2005: 100 (8): 1886-1891.
57. De Vos M, Hayward BE, Charlton R et al. PMS2 mutations in childhood cancer. J Natl Cancer Inst 2006: 98 (5): 358-361.
58. Tithecott GA, Filler R, Sherman PM. Turcot's syndrome: A diagnostic consideration in a child with primary adenocarcinoma of the colon. J Pediatr Surg 1989: 24 (11): 1189-1191.
59. Will O, Carvajal-Carmona LG, Gorman P et al. Homozygous PMS2 deletion causes a severe colorectal cancer and multiple adenoma phenotype without extraintestinal cancer. Gastroenterology 2007: 132 (2): 527-530.
60. Nicolaides NC, Littman SJ, Modrich P et al. A naturally occurring hPMS2 mutation can confer a dominant negative mutator phenotype. Mol Cell Biol 1998: 18 (3): 1635-1641.
61. Yamada NA, Castro A, Farber RA. Variation in the extent of microsatellite instability in human cell lines with defects in different mismatch repair genes. Mutagenesis 2003: 18 (3): 277-282.
62. Glaab WE, Risinger JI, Umar A et al. Characterization of distinct human endometrial carcinoma cell lines deficient in mismatch repair that originated from a single tumor. J Biol Chem 1998: 273 (41): 26662-26669.
63. Risinger JI, Umar A, Barrett JC et al. A hPMS2 mutant cell line is defective in strand-specific mismatch repair. J Biol Chem 1995: 270 (31): 18183-18186.
64. Risinger JI, Umar A, Glaab WE et al. Single gene complementation of the hPMS2 defect in HEC-1-A endometrial carcinoma cells. Cancer Res 1998: 58 (14): 2978-2981.
65. Baker SM, Plug AW, Prolla TA et al. Involvement of mouse Mlh1 in DNA mismatch repair and meiotic crossing over. Nat Genet 1996: 13 (3): 336-342.
66. de Wind N, Dekker M, Berns A et al. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer. Cell 1995: 82 (2): 321-330.
67. Edelmann W, Cohen PE, Kane M et al. Meiotic pachytene arrest in MLH1-deficient mice. Cell 1996: 85 (7): 1125-1134.
68. Prolla TA, Baker SM, Harris AC et al. Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair. Nat Genet 1998: 18 (3): 276-279.
69. Reitmair AH, Schmits R, Ewel A et al. MSH2 deficient mice are viable and susceptible to lymphoid tumours. Nat Genet 1995: 11 (1): 64-70.
70. Edelmann W, Yang K, Umar A et al. Mutation in the mismatch repair gene Msh6 causes cancer susceptibility. Cell 1997: 91 (4): 467-477.
71. Yao X, Buermeyer AB, Narayanan L et al. Different mutator phenotypes in Mlh1- versus Pms2-deficient mice. Proc Natl Acad Sci U S A 1999: 96 (12): 6850-6855.
72. Narayanan L, Fritzell JA, Baker SM et al. Elevated levels of mutation in multiple tissues of mice deficient in the DNA mismatch repair gene Pms2. Proc Natl Acad Sci U S A 1997: 94 (7): 3122-3127.
73. Wei K, Kucherlapati R, Edelmann W. Mouse models for human DNA mismatch-repair gene defects. Trends Mol Med 2002: 8 (7): 346-353.
74. Friedman JMR, Vincent M. Neurofibromatosis: Phenotype, natural history, and pathogenesis. Baltimore: Johns Hopkins University Press, 1999.
75. North K. Neurofibromatosis type 1. Am J Med Genet 2000: 97 (2): 119-127.
76. Landau M, Krafchik BR. The diagnostic value of cafe-au-lait macules. J Am Acad Dermatol 1999: 40 (6 Pt 1): 877-890; quiz 891-892.
77. Wang Q, Montmain G, Ruano E et al. Neurofibromatosis type 1 gene as a mutational target in a mismatch repair-deficient cell type. Hum Genet 2003: 112 (2): 117-123.
78. Gutmann DH, Winkeler E, Kabbarah O et al. Mlh1 deficiency accelerates myeloid leukemogenesis in neurofibromatosis 1 (Nf1) heterozygous mice. Oncogene 2003: 22 (29): 4581-4585.
79. Pedroni M, Tamassia MG, Percesepe A et al. Microsatellite instability in multiple colorectal tumors. Int J Cancer 1999: 81 (1): 1-5.
80. Woerner SM, Kloor M, Mueller A et al. Microsatellite instability of selective target genes in HNPCC-associated colon adenomas. Oncogene 2005: 24 (15): 2525-2535.
81. Boland CR, Thibodeau SN, Hamilton SR et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998: 58 (22): 5248-5257.
82. Markowitz S, Wang J, Myeroff L et al. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 1995: 268 (5215): 1336-1338.
83. Parsons R, Myeroff LL, Liu B et al. Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res 1995: 55 (23): 5548-5550.
84. Peltomaki P. Deficient DNA mismatch repair: A common etiologic factor for colon cancer. Hum Mol Genet 2001: 10 (7): 735-740.
85. Felton K. The effect of DNA mismatch repair deficiency in a MSH2 null individual. Medical sciences, medical genetics, vol. master of science. Edmonton: University of Alberta, 2005.
86. Gottschling S, Reinhard H, Pagenstecher C. et al. Hypothesis: Possible role of retinoic acid therapy in patients with biallelic mismatch repair gene defects. Eur J Pediatr 2007 (Epub ahead of print).